Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (9)

2024

  1. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849

2023

  1. Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming

    Journal of Hepatology, Vol. 79, Núm. 3, pp. 728-740

  2. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis

    Cell death & disease, Vol. 14, Núm. 8, pp. 514

2021

  1. Abnormal liver function test in patients infected with coronavirus (Sars-cov-2): A retrospective single-center study from spain

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-18

2017

  1. The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells

    Hepatology, Vol. 65, Núm. 6, pp. 2031-2044

2016

  1. Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats

    Journal of Hepatology, Vol. 64, Núm. 4, pp. 834-842

2005

  1. Oxidation of specific methionine and tryptophan residues of apolipoprotein A-I in hepatocarcinogenesis

    Proteomics, Vol. 5, Núm. 18, pp. 4964-4972

2004

  1. Methylthioadenosine phosphorylase gene expression is impaired in human liver cirrhosis and hepatocarcinoma

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1690, Núm. 3, pp. 276-284

2000

  1. Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation: Implications for MAT1A silencing during transformation

    FASEB Journal, Vol. 14, Núm. 1, pp. 95-102